Formed in 1999, Oncology Systems Limited (OSL) is the largest independent provider of radiotherapy equipment and software in the UK. OSL’s customers include the UK’s NHS and private radiotherapy facilities, and public and private providers in the Republic of Ireland.
OSL’s products enable clinicians to deliver the highest quality therapies for the treatment of cancer. These include: intensity modulated radiotherapy (IMRT), image guided radiotherapy (IGRT), stereotactic radiosurgery (SRS), stereotactic ablative radiotherapy (SABR) and stereotactic body radiotherapy (SBRT).
OSL provides a wide range of clinical and technical radiation therapy equipment from thermoplastic to 4D simulation and imaging, in the areas of immobilisation, treatment planning and medical physics QA. The company benefits from the significant clinical experience gained by members of staff.
In 2003, OSL achieved the international quality accreditation to ISO 9001:2001, which was upgraded to ISO 9000:2008. From 2013 onward OSL incorporated the requirements of ISO 13485:2003, EN ISO 13485:2012 and attained Directive 93/42/EEC on medical devices, Annex II (excluding Section 4) for its own manufactured software; OnQ rts.